vimarsana.com
Home
Live Updates
Interchangeable Biosimilar Automatic Substitution : vimarsan
Interchangeable Biosimilar Automatic Substitution : vimarsan
Interchangeable Biosimilar Automatic Substitution
Jonathan Kay, MD, and Kimberly C. Chen, DO, MSHLM, discuss clinical and financial concerns related to automatic substitution at the pharmacy for an interchangeable biosimilar from a payer perspective.
Related Keywords
Kimberlyc Chen ,
Jonathan Kay ,
Ryan Haumschild ,
,
Interchangeable Biosimilar ,
Automatic Substitution ,
Biosimilars ,
Pharmacy ,
Payer Perspective ,
Reference Product ,
Financial Concerns ,
Clinical Concerns ,